Genalyte, Inc.

📍 San Diego, United States👥 84 employees💰 Last funded Jan 2022
Biotechnology🌐 genalyte.com
Website LinkedIn
Genalyte is a tech-enabled, full service CAP accredited and CLIA certified laboratory. We perform the majority of tests with our rapidly deployable mobile laboratory in under 30 minutes. Our central lab handles tests that cannot be performed onsite. All results are run through CloudLab, our proprietary tele-health platform, for quality oversight and monitoring by Clinical Lab Scientists. Core to our mobile capabilities is the Maverick platform, which has unprecedented serological testing functionality - permitting up to 64 simultaneous immunoassays on whole blood in 15 minutes. The platform achieved FDA clearance in Oct 2019. In these unprecedented times, we have developed a rapid COVID-19 serology test for IgG and IgM antibodies, while simultaneously including flu and other respiratory illnesses for differential diagnosis. For more information, visit www.genalyte.com.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2010–2022 · investors recorded per year
20101201212020120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Genalyte, Inc.?
Genalyte, Inc. has 4 investors on record on gritt.io.
When did Genalyte, Inc. last raise funding?
The most recent investment in Genalyte, Inc. recorded on gritt.io was in January 2022.
What industry is Genalyte, Inc. in?
Genalyte, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Genalyte, Inc. based?
Genalyte, Inc. is headquartered in San Diego, United States.